NRF2 is essential for adaptative browning of white adipocytes
Journal article, 2023

White adipose tissue browning, defined by accelerated mitochondrial metabolism and biogenesis, is considered a promising mean to treat or prevent obesity-associated metabolic disturbances. We hypothesize that redox stress acutely leads to increased production of reactive oxygen species (ROS), which activate electrophile sensor nuclear factor erythroid 2-Related Factor 2 (NRF2) that over time results in an adaptive adipose tissue browning process. To test this, we have exploited adipocyte-specific NRF2 knockout mice and cultured adipocytes and analyzed time- and dose-dependent effect of NAC and lactate treatment on antioxidant expression and browning-like processes. We found that short-term antioxidant treatment with N-acetylcysteine (NAC) induced reductive stress as evident from increased intracellular NADH levels, increased ROS-production, reduced oxygen consumption rate (OCR), and increased NRF2 levels in white adipocytes. In contrast, and in line with our hypothesis, longer-term NAC treatment led to a NRF2-dependent browning response. Lactate treatment elicited similar effects as NAC, and mechanistically, these NRF2-dependent adipocyte browning responses in vitro were mediated by increased heme oxygenase-1 (HMOX1) activity. Moreover, this NRF2-HMOX1 axis was also important for β3-adrenergic receptor activation-induced adipose tissue browning in vivo. In conclusion, our findings show that administration of exogenous antioxidants can affect biological function not solely through ROS neutralization, but also through reductive stress. We also demonstrate that NRF2 is essential for white adipose tissue browning processes.

Redox stress

Lactate

Adipose tissue

N-acetylcysteine

NRF2

Author

Marco Bauzá-Thorbrügge

University of Gothenburg

Eduard Peris

University of Gothenburg

Shabnam Zamani

University of Gothenburg

Peter Micallef

University of Gothenburg

Alexandra Paul

Chalmers, Life Sciences, Chemical Biology

The University of Texas at Austin

Stefano Bartesaghi

AstraZeneca AB

Anna Benrick

University of Gothenburg

University of Skövde

Ingrid Wernstedt Asterholm

University of Gothenburg

Redox Biology

2213-2317 (ISSN)

Vol. 68 102951

Subject Categories

Neurosciences

Physiology

DOI

10.1016/j.redox.2023.102951

PubMed

37931470

More information

Latest update

11/17/2023